Literature DB >> 10468973

Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501.

J M Heward1, A Allahabadia, M C Sheppard, A H Barnett, J A Franklyn, S C Gough.   

Abstract

OBJECTIVE: The large multifunctional proteasome (LMP) molecules are over expressed in thyrocytes, the target cells of Graves' disease, and the LMP genes are found within the MHC class II region. The LMP genes may therefore play a role in susceptibility to Graves' disease. The aim of this this study was to determine whether polymorphisms of the LMP genes, LMP 2 and LMP 7 are in linkage disequilibrium with Graves' disease.
DESIGN: Target DNA was amplified using the polymerase chain reaction. The distribution of an Arg-His polymorphism in the LMP 2 gene and a G/T polymorphism in the LMP 7 gene, both of which lead to the presence of an HhaI restriction site, were investigated in a population based case control and family based study in patients with Graves' disease. PATIENTS: We obtained DNA from 306 patients with Graves' disease and 364 control subjects for the population based case-control study. In an independent family based study, DNA was obtained from 129 families including both parents, an affected sibling with Graves' disease and an unaffected sibling. All families, patients and control subjects were white caucasians. MEASUREMENTS: Frequencies of the alleles and genotypes of the LMP 2 and LMP 7 genes were compared between patients and control subjects using the chi2 test. Transmission of alleles from heterozygous parents to affected and unaffected offspring was assessed using the transmission disequilibrium test (TDT).
RESULTS: In the case control study, no difference in allele or genotype frequency was seen between patients and control subjects at the LMP7 locus. At the LMP2 locus the R allele and the RH genotype were increased in subjects with Graves' disease when compared with control subjects (R allele: 36.3% vs. 29.5%, pc = 0. 0164; RH genotype: 56.5% vs. 45%, pc = 0.0102). However, the R allele was in linkage disequilibrium with the associated HLA DRB1*0304-DQB1*02-DQA1*0501 haplotype, delta = 0.102. Within the family based study, no preferential allelic transmission was seen from heterozygote parents to offspring at either loci.
CONCLUSION: These results show that association of the LMP 2 locus with Graves' disease is due to linkage disequilibrium with the associated HLA haplotype DRB1*0304-DQB1*02-DQA1*0501.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468973     DOI: 10.1046/j.1365-2265.1999.00755.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Microsatellite genotyping of chromosome 14q13.2-14q13 in the vicinity of proteasomal gene PSMA6 and association with Graves' disease in the Latvian population.

Authors:  Tatjana Sjakste; Jelena Eglite; Arturs Sochnevs; Mara Marga; Valdis Pirags; Yrjö Collan; Nikolajs Sjakste
Journal:  Immunogenetics       Date:  2004-06-17       Impact factor: 2.846

Review 2.  Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond.

Authors:  M J Simmonds; S C L Gough
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

3.  Immunogenetic mechanisms leading to thyroid autoimmunity: recent advances in identifying susceptibility genes and regions.

Authors:  Oliver J Brand; Stephen C L Gough
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

4.  Immunogenetics of Hashimoto's thyroiditis.

Authors:  Dimitry A Chistiakov
Journal:  J Autoimmune Dis       Date:  2005-03-11

5.  Molecular mechanisms of uterine leiomyosarcomas: involvement of defect in LMP2 expression.

Authors:  Takuma Hayashi; Yuto Shimamura; Taro Saegusa; Akiko Horiuchi; Yukihiro Kobayashi; Nobuyoshi Hiraoka; Yae Kanai; Hiroyuki Aburatani; Kenji Sano; Ikuo Konishi
Journal:  Gene Regul Syst Bio       Date:  2008-07-22

6.  PSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancer.

Authors:  Ji Eun Park; Lin Ao; Zachary Miller; Kyungbo Kim; Ying Wu; Eun Ryoung Jang; Eun Young Lee; Kyung Bo Kim; Wooin Lee
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

7.  Genetics of proteasome diseases.

Authors:  Aldrin V Gomes
Journal:  Scientifica (Cairo)       Date:  2013-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.